The physicochemical and biopharmaceutic properties of a preclinical candidate are defined by the candidate’s structure which directly affects its transition into and ease of progression through drug development and clinical evaluation. Our speakers will discuss the many groups involved, what they do, why they do it and how the properties of the candidate impact decisions.
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.
;void(0);){kind=link}